MSL
CRL icon

Mackay Shields LLC’s Charles River Laboratories CRL Stock Holding History

Mackay Shields LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,251
Closed -$2.06M – 350
2022
Q1 		$2.06M Sell
7,251
-287
-4% -$88.5K 0.02% 559
2021
Q4 		$2.84M Sell
7,538
-152
-2% -$59.1K 0.02% 497
2021
Q3 		$3.17M Sell
7,690
-455
-6% -$189K 0.03% 438
2021
Q2 		$3.01M Sell
8,145
-23,706
-74% -$7.92M 0.03% 457
2021
Q1 		$9.23M Sell
31,851
-32,568
-51% -$9.05M 0.07% 303
2020
Q4 		$16.1M Sell
64,419
-5,600
-8% -$1.33M 0.11% 199
2020
Q3 		$15.9M Sell
70,019
-149
-0.2% -$30.9K 0.11% 201
2020
Q2 		$12.2M Sell
70,168
-32,312
-32% -$5.16M 0.1% 241
2020
Q1 		$12.9M Sell
102,480
-18,678
-15% -$2.8M 0.12% 195
2019
Q4 		$18.5M Buy
121,158
+51,844
+75% +$7.18M 0.13% 194
2019
Q3 		$9.18M Buy
69,314
+19,679
+40% +$2.64M 0.06% 357
2019
Q2 		$7.04M Sell
49,635
-73,278
-60% -$9.94M 0.05% 426
2019
Q1 		$17.9M Sell
122,913
-1,788
-1% -$235K 0.13% 197
2018
Q4 		$14.1M Buy
+124,701
New +$15.6M 0.11% 224
2018
Q3 		– Sell
-46,182
Closed -$5.18M – 1168
2018
Q2 		$5.18M Buy
46,182
+33,781
+272% +$3.65M 0.04% 464
2018
Q1 		$1.32M Buy
+12,401
New +$1.34M 0.01% 912

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mackay Shields LLC's CRL Position: Q2 2022 in Review

Mackay Shields LLC sold out of Charles River Laboratories (CRL) in Q2 2022, closing a stake of 7,251 shares — an estimated $2.06M sold.

Mackay Shields LLC first reported a position in CRL in Q1 2018 and held it in 16 quarters. The position peaked at $18.5M in Q4 2019. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

  • Mackay Shields LLC reported no remaining Charles River Laboratories position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 7,251 Charles River Laboratories shares in Q2 2022, an estimated $2.06M.
  • Mackay Shields LLC first reported a position in Charles River Laboratories in Q1 2018 and held it in 16 quarters.
  • Mackay Shields LLC's Charles River Laboratories position peaked at $18.5M in Q4 2019.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.